[ANR] YoY Quarter Result on 30-Dec-2012 [#Q2]

Stock
[ANR] Anatara Lifesciences Ltd
Announcement Date
30-Dec-2012
Financial Year
2013
Quarter
30-Dec-2012 [#Q2]
Profit Trend
QoQ-
YoY-
Quarter Report
ANR's Result
ANR's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 30/12/12 CAGR
Revenue 487 853 1,936 165 0 45 45 48.67%
PBT -2,021 -1,710 -402 -1,179 -776 -123 -93 66.97%
Tax 0 0 0 106 48 0 0 -
NP -2,021 -1,710 -402 -1,179 -776 -123 -93 66.97%
Tax Rate - - - - - - - -
Total Cost 2,508 2,563 2,338 1,344 776 168 138 62.07%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 30/12/12 CAGR
NP Margin -415.32 -200.56 -20.78 -713.59 0.00 -273.50 -205.99 12.38%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/01/14 30/12/12 CAGR
EPS -0.04 -0.03 -0.01 -0.03 -0.03 -0.01 -0.01 25.96%
EPS Diluted -0.04 -0.03 -0.01 -0.03 -0.03 -0.01 -0.01 25.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.